June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$247.93 |
Change
0.480(0.19%) |
Mkt cap ! $120.0B | |||
| Open | High | Low | Value | Volume |
| $247.65 | $249.87 | $245.75 | $129.6M | 521.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 76 | $247.92 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $247.95 | 1 | 1 |
View Market Depth
| Last trade - 15.52pm 17/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |